Man-To-Man Show Episode 3

Member Access Required

Join Now

Already a member? Sign In

Timeline

00:01

The episode opens by addressing dosing concerns during testosterone therapy. Restraint is emphasized.

14:05

Attention turns to symptom interpretation before lab confirmation. Context is reinforced.

35:20

The discussion explains how labs and dosing schedules guide safe decisions. Integration is highlighted.

56:45

Questions then focus on avoiding overcorrection. Stability is emphasized.

81:05

The episode concludes by framing testosterone therapy as long-term care requiring measured adjustments. Monitoring and perspective are reinforced.

Video Summary

This Man-To-Man episode focuses on practical questions surrounding testosterone dosing and symptom interpretation. It explains how short-term symptom changes can tempt premature dose adjustments. Testosterone therapy is framed as requiring restraint and contextual review.
A central portion discusses how labs, dosing schedules, and symptom duration should be evaluated together before making changes. The episode emphasizes avoiding overcorrection driven by anxiety or comparison. Contextual interpretation is highlighted as essential to stability.
The closing segment reinforces testosterone therapy as structured, long-term clinical care. Ongoing monitoring, proportional responses, and expectation alignment are emphasized. Hormone care is positioned as benefiting from measured decision-making.

Drug Callouts

Testosterone

Testosterone is an androgen hormone used therapeutically to treat confirmed testosterone deficiency and related symptoms. In this episode, testosterone dosing decisions are discussed in detail.

Condition Callouts

Testosterone deficiency

Testosterone deficiency is a condition marked by insufficient testosterone levels with associated symptoms. Hypogonadism is referenced as the underlying diagnostic category discussed in relation to therapy.

Hypogonadism

Key Takeaways

Overcorrection increases instability.
Symptoms should be reviewed with labs.
Dose changes require context.
Restraint supports long-term success.
Monitoring guides safe adjustments.